breakdown of cartilage proteoglycans. The substance responsible for this effect was termed catabolin.4 Similar effects were described for mononuclear cell factor,5 a product of stimulated human blood monocytes. When purified to homogeneity, catabolin and mononuclear cell factor were shown to have properties identical to those of ILl. 6 7 It is now known that ILl stimulates the release of metalloproteinases from chondrocytes.8-' Interestingly, ILl-like activity has been identified in synovial fluid from patients with various types of joint disease." 12 Moreover, raised levels of cartilage derived proteases have been detected in cartilage specimens from patients with osteoarthritis. 13 14 In the present study we describe the effects of murine recombinant ILl on chondrocyte metabolism, using anatomically intact homologous articular cartilage-the murine patella. Apart from an enhancing effect on proteoglycan breakdown, ILl was shown to inhibit severely chondrocyte proteoglycan synthesis as measured by 35S incorporation. Whole murine patellae were isolated from C57BI mice leaving the patella embedded in a minimal amount of surrounding tissue and used to measure chondrocyte metabolism as described previously. 15 16 In brief, patella specimens were cultured in RPMI-5% fetal calf serum (FRow) under 5% CO2 with or without ILl. Culture medium was refreshed every day. To determine chondrocyte proteoglycan synthesis the specimens were subsequently pulsed with 740 kBq [ trations of ILl of 0. 1 U/ml or below were essentially without effect. A plateau of maximal inhibition was reached at ILl concentrations of 3 U/ml and higher.
In multiple experiments inhibition ranged between 50 and 65% with an ILl concentration of 3 U/ml. Control incubations with recombinant IL2 (Amersham, England), tested in doses up to 30 U/ml, failed to inhibit proteoglycan synthesis. To verify that we were really measuring ILl mediated inhibition of synthesis and not enhanced breakdown of new proteoglycan synthesised at the same rate we checked the culture supematant for labelled proteoglycan fragments. The amount released during the three hour 35S pulse period was less than 10% of the amount incorporated in the cartilage for both the control incubation and after 48 hours of ILl exposure, and was therefore negligible. Next, the effect on sulphate incorporation of time of exposure to ILl was explored. After 24 hours ILl exposure the suppression of chondrocyte synthesis (3 S incorporation) was variable (5-20%), only rarely reaching statistical significance. Exposure of patellar cartilage to ILl for 48 hours consistently resulted in extensive inhibition of proteoglycan synthesis (Table 2 ). This effect seems not to depend upon exposure of the cartilage to ILl for 48 hours as incubation with ILl for 24 hours followed by a (Fig. la) .
When the patellae were cultured in the presence of ILl, clear cut suppression of labelling intensity was observed (Fig. lb) The uptake reached equilibrium within 30 minutes, but the partition coefficient of the anionic ILl (pl 5) remained far below 1 (Table 6) . A partition coefficient of 0-2 indicates that the local concentration is about five times less than the ILL concentration in the incubation medium. In contrast, the cationic protein amidated bovine serum albumin (aBSA; pl 8.5-9) 19 20' accumulated to a high extent in the cartilage and equilibrium was not reached even after four hours (Table 6 ). Figure 3 depicts the autoradiography of ILl and aBSA partition. In contrast with the high affinity of aBSA for the patellar cartilage (Fig. 3b) , ILl was predominantly taken up by the surrounding tissue (Fig. 3a) . Higher magnification of the cartilage (Figs 3c and d) showed that most of the ILl radiolabel was present as a superficial lining layer, and that the quantitative measurement of the partition (Table 6 ) strongly overestimated the actual concentration within the matrix. If, after [1251]ILl exposure, the patella specimens were washed with saline and then prepared for autoradiography, labelling was no longer detectable, either at the cartilage surface or within the matrix. The label present within the matrix showed a diffuse pattern over the whole cartilage area.
OTHER EFFECTS OF MURINE RECOMBINANT I L 1
Murine ILl (pl 5) was examined in a number of other assays to compare its activity with that of native ILl. In vivo, in the mouse, we found it to induce fever, leucocytosis, i.e., elevation of granulocyte numbers, and acute phase reactant synthesis (serum amyloid A). In vitro it induced proliferation of thymocytes in the LAF assay. In the latter assay the ILl was found to give 1 unit of activity consistently in the 10-40 pg/ml range. Preliminary experiments further indicated that the ILl preparation also caused cartilage breakdown and proteoglycan synthesis inhibition in vivo upon intraarticular injection in knee joints (manuscript in preparation).
Discussion
The present study demonstrated that murine recombinant ILl not only enhanced proteoglycan breakdown but also extensively inhibited chondrocyte proteoglycan synthesis in intact murine articular cartilage. As a control the lymphokine IL2 was without effect. The combined effects of enhanced proteoglycan breakdown and inhibition ofrestoration underline the destructive potential of ILl in disease states characterised by ILl overproduction. ILl mediated loss of proteoglycans from the cartilage matrix does not seem to be a selective process. Newly synthesised proteoglycan and proteoglycan processed for four days are affected equally (Table 5 ). Earlier studies with catabolin yielded similar results. Release of newly synthesised (labelled) proteoglycans and unlabelled proteoglycans from catabolin treated cartilage followed the same pattern.21 These the continuing suppression of proteoglycan synthesis. The suppression found in the models of experimental arthritis was of the same order of magnitude (50-60%) as that obtained with ILl in vitro. In vivo it was observed that there was a higher vulnerability of chondrocytes in certain regions of the articular cartilage.30 For instance, suppression of sulphate incorporation was more pronounced in chondrocytes of the central area of the patellar cartilage than in the margins.30 Evidence for an enhanced susceptibility of particular chondrocytes to ILl effects was not observed in vitro in the present study. This could indicate that ILl is not the mediator of the cartilage damage seen in these models. In vivo, however, load bearing may give rise to regional differences. Moreover, diffusion of proteolytic inhibitors or other protective factors from the margins, supplied in vivo, may lead to more pronounced suppression in the central area.
The importance of ILl as a mediator of cartilage destruction in chronic destructive arthritis is yet to be determined. ILI activity has been detected in synovial fluid of patients with rheumatoid arthritis. 1112 Inhibitors are also present in high amounts, however, and measurement of consistent ILl activity depends upon separation of ILl and its inhibitors by gel chromatography.34 35 Some inhibitors ap ear only able to block the ILl comitogenic assay, but recently an inhibitor has been described which blocked fibroblast collagenase production, 38 
